Stress Inoculation Training in the Control of THC Toxicities

References

• Abel E. L. Marihuana: The First Twelve Thousand Years. Plenum Press, New York 1980
   Google Scholar
• Bernstein D. A., Borkovec J. D. Progressive Relaxation Training: A Manual for the Helping Professions. Research Press, Champaign, IL 1973
   Google Scholar
• Bowrey T. A Geographical Account of Countries Round the Bay of Bengal, 1669 to 1679. Kraus Reprint, Nendeln, Liechtenstein 1967
   Google Scholar
• Carey M. P., Burish T. G., Brenner D. E. Delta-9-tetrahydrocannabinol in cancer chemotherapy: Research problems and issues. Ann. Intern. Med 1983; 99: 106–114
   PubMed Web of Science ®Google Scholar
• Chang A. E., Shiling D. J., Stillman R. C., Goldberg N. H., Seipp C., Barof-Sky I., Rosenberg S. A. A prospective evaluation of delta-9-tetrahydrocanna-binol as an antiemetic in patients receiving Adriamycin and Cytoxan chemotherapy. Cancer 1981; 47: 1746–1751
   PubMed Web of Science ®Google Scholar
• Chang A. E., Shiling D. J., Stillman R. C., Goldberg N. H., Seipp C. A., Bar-Ofsky I., Simon R. M., Rosenberg S. A. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. Ann. Intern. Med 1979; 91: 819–824
   PubMed Web of Science ®Google Scholar
• Colls B. M., Ferry D. G., Gray A. J., Harvey V. J., Mc Queen E. G. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylpera-zine in patients undergoing cancer chemotherapy. New Zealand Med. J 1980; 91: 449–451
   PubMed Web of Science ®Google Scholar
• Ekert H., Waters K. D., Jurk I. H., Mobilia J., Loughnan P. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med. J. Australia 1979; 2: 657–659
   PubMed Web of Science ®Google Scholar
• Frytak S., Moertel C. G., O'Fallon J. R., Rubin J., Creagan E. T., O'con-Nell M. J., Schutt A. J., Schwartan N. W. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy: A comparison with prochlorperazine and a placebo. Ann. Intern. Med 1979; 91: 825–830
   PubMed Web of Science ®Google Scholar
• Garb S., Beers A. L., Bograd M., Mc Mahon R. T., Mangalik A., Ashmann A., Levine S. Two-pronged study of tetrahydrocannabinol (THC) prevention of vomiting from cancer chemotherapy. IRCS Med. Sci 1980; 8: 203–204
   Google Scholar
• Gralla R. J., Tyson L. B., Clark R. A., Bordin L. A., Kelsen D. P., Kal-Man L. B. Antiemetic trials with high dose metoclopramide: Superiority over Thc, and preservation of efficacy in subsequent chemotherapy courses. Proceedings of the American Society for Cancer Research I American Society of Clinical Oncology. 1982; Vol. 23: 58
   Google Scholar
• Hollister L. E., Overall J. E. Dimensions of marihuana experience. Drug Alcohol Depend 1975–1976; 1: 155–164
   PubMed Web of Science ®Google Scholar
• Jaremko M. E. A component analysis of stress inoculation: Review and prospectus. Cognitive Ther. Res 1979; 3: 35–48
   Web of Science ®Google Scholar
• Kluin-Neleman J. C., Neleman F. A., Meuwissen O. J. A. Th., Maes R. A.A. Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy: A double-blind crossover trial against placebo. Vet. Hum. Toxicol 1979; 21: 338–340
   PubMedGoogle Scholar
• Levitt M., Wilson A., Bowman D., Kemel S., Krepart G., Marks V., Schipper H., Thomson G., Weinerman B., Weinerman R. Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg. of delta-9-tetrahydrocannabinol in cancer chemotherapy: Ophthalmologic implications. J. Clin. Pharmacol 1981; 21: 103S–109S
   Web of Science ®Google Scholar
• Lucas V. S., Laszlo J. Delta-9-tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. J. Am. Med. Assoc 1980; 243: 1241–1243
   PubMed Web of Science ®Google Scholar
• Mc Cabe M., Smith F. P., Goldberg D., Macdonald J., Woolley P. V., Warren R., Brodeur R., Schein P. S. Comparative trial of oral 9-tetrahydro-cannabinol (THC) and prochlorperazine (PCZ) for cancer chemotherapy-related nausea and vomiting. Proceedings of the American Association for Cancer Research/ American Society of Clinical Oncology. 1981; Vol. 22: 416
   Google Scholar
• Meichenbaum D. Cognitive-Behavior Modification. Plenum Press, New York 1977
   Google Scholar
• Meichenbaum D., Cameron R. Stress-inoculation: A skills training approach to anxiety management. 1972, Unpublished manuscript
   Google Scholar
• Neidhart J. A., Gagen M. M., Wilson H. E., Young D. C. Comparative trial of the antiemetic effects of THC and haloperidol. J. Clin. Pharmacol 1981; 21: 38S–42S
   Web of Science ®Google Scholar
• Novaco R. Treatment of chronic anger through cognitive and relaxation controls. J. Consult. Clin. Psychol 1976; 44: 681
   PubMed Web of Science ®Google Scholar
• Orr L. E., Mc Kernan J. F., Bloome B. Antiemetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Arch. Intern. Med 1980; 140: 1431–1433
   PubMedGoogle Scholar
• Penta J. S., Poster D. S., Bruno S., Mac Donald J. S. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy. J. Clin. Pharmacol 1981; 21: 11S–22S
   Web of Science ®Google Scholar
• Roffman R. A. The controlled substances therapeutic research act in the State of Washington. J. Clin. Pharmacol 1981; 21: 133S–140S
   PubMed Web of Science ®Google Scholar
• Sallan S. E., Cronin C., Zelen M., Zinberg N. E. Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of delta-9-tetrahydro-cannabinol and prochlorperazine. N. Engl. J. Med 1980; 302: 135–138
   PubMed Web of Science ®Google Scholar
• Sallan S. E., Zinberg N. E., Frei E. Antiemetic effect of delta-9-tetrahydrocan-nabinol in patients receiving cancer chemotherapy. N. Engl. J. Med 1975; 293: 795–797
   PubMed Web of Science ®Google Scholar
• Sweet D. L., Miller N. J., Weddington W., Senay E., Sushelsky L. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy: A pilot study. J. Clin. Pharmacol 1981; 21: 70S–75S
   PubMed Web of Science ®Google Scholar
• Ungerleider J. T., Andrysiak T., Fairbanks L., Goodnight J., Sarna G., Jamison K. Cannabis and cancer chemotherapy: A comparison of oral delta-9-THC and prochlorperazine. Cancer 1982; 50: 636–645
   PubMed Web of Science ®Google Scholar